{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:04:11Z","timestamp":1772607851477,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000669"],"award-info":[{"award-number":["82000669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXY-071C"],"award-info":[{"award-number":["TJYXZDXY-071C"]}]},{"name":"Tianjin Key Medical Discipline Construction Project","award":["TJYXZDXY-071C"],"award-info":[{"award-number":["TJYXZDXY-071C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thyroid dysfunction is common in patients with nephrotic syndrome, especially patients with primary membranous nephropathy (pMN). In view of both MN and thyroid dysfunction are associated with autoimmunity, the current study aimed to elucidate the significance of thyroid dysfunction in patients with pMN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Four hundred and twenty patients with biopsy-proven pMN from 2018\u20132021 were retrospectively enrolled. Clinical and pathological parameters, and treatment response of patients with and without thyroid dysfunction were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ninety-one (21.7%) patients with pMN suffered from thyroid dysfunction, among which subclinical hypothyroidism (52.7%) was the main disorder. Compared to patients with normal thyroid function, patients with thyroid dysfunction presented with a higher level of proteinuria, a lower level of serum albumin, a higher level of serum creatinine and more severe tubulointerstitial injury at the time of biopsy. But the positive rate and level of circulating anti-phospholipase A2 receptor (PLA2R) antibody were comparable between these two groups. Though following the similar treatment, the percentage of no response to treatment were significantly higher in the patients with thyroid dysfunction (38.6 vs. 20.0%, <jats:italic>P<\/jats:italic>\u2009=\u20090.003). Similar to the urinary protein and the positivity of anti-PLA2R antibody, multivariate COX analysis showed thyroid dysfunction was also identified as an independent risk factor for the failure to remission (HR\u2009=\u20091.91, 95%CI, 1.07\u20133.40, <jats:italic>P<\/jats:italic>\u2009=\u20090.029).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, thyroid dysfunction is common in the patients with pMN and might predict a severe clinical manifestation and a poor clinical outcome, which indicated that the thyroid dysfunction might be involved in the disease progression of pMN.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-03023-y","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T09:02:38Z","timestamp":1670662958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Significance of thyroid dysfunction in the patients with primary membranous nephropathy"],"prefix":"10.1186","volume":"23","author":[{"given":"Qiu-hua","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ya","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie-kun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"issue":"1","key":"3023_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ccr3.2573","volume":"8","author":"G Singhania","year":"2020","unstructured":"Singhania G, Singhania N. Membranous nephropathy associated with profound hypothyroidism. Clin Case Rep. 2020;8(1):120\u20132.","journal-title":"Clin Case Rep."},{"issue":"5","key":"3023_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/1570161115999170207114706","volume":"15","author":"FD Mario","year":"2017","unstructured":"Mario FD, Pofi R, Gigante A, Rivoli L, Rosato E, Isidori AM, Cianci R, Barbano B. Hypothyroidism and Nephrotic Syndrome: Why, When and How to Treat. Curr Vasc Pharmacol. 2017;15(5):398\u2013403.","journal-title":"Curr Vasc Pharmacol."},{"issue":"2","key":"3023_CR3","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1210\/clinem\/dgaa872","volume":"106","author":"N Kwong","year":"2021","unstructured":"Kwong N, Medici M, Marqusee E, Wassner AJ. Severity of Proteinuria Is Directly Associated With Risk of Hypothyroidism in Adults. J Clin Endocrinol Metab. 2021;106(2):e757\u201362.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"3023_CR4","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1038\/s41598-019-42905-4","volume":"9","author":"LZ Li","year":"2019","unstructured":"Li LZ, Hu Y, Ai SL, Cheng L, Liu J, Morris E, Li Y, Gou SJ, Fu P. The relationship between thyroid dysfunction and nephrotic syndrome: a clinicopathological study. Sci Rep. 2019;9(1):6421.","journal-title":"Sci Rep."},{"issue":"2","key":"3023_CR5","first-page":"139","volume":"92","author":"D Jain","year":"2019","unstructured":"Jain D, Aggarwal HK, Pavan Kumar YM, Jain P. Evaluation of thyroid dysfunction in patients with nephrotic syndrome. Med Pharm Rep. 2019;92(2):139\u201344.","journal-title":"Med Pharm Rep."},{"issue":"11","key":"3023_CR6","first-page":"483","volume":"66","author":"R Gilles","year":"2008","unstructured":"Gilles R, den Heijer M, Ross AH, Sweep FC, Hermus AR, Wetzels JF. Thyroid function in patients with proteinuria. Neth J Med. 2008;66(11):483\u20135.","journal-title":"Neth J Med."},{"issue":"9","key":"3023_CR7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s11255-020-02778-3","volume":"53","author":"S Singh","year":"2021","unstructured":"Singh S, Mishra OP, Mandal PP, Patel PS, Sharma SS, Saini H, Rani K, Chandrasekhar S, Singh MP. Thyroid function in patients with idiopathic nephrotic syndrome. Int Urol Nephrol. 2021;53(9):1859\u201364.","journal-title":"Int Urol Nephrol."},{"key":"3023_CR8","doi-asserted-by":"crossref","unstructured":"Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022.","DOI":"10.1038\/s41581-022-00564-1"},{"issue":"1","key":"3023_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00467-008-1009-5","volume":"24","author":"P Ronco","year":"2009","unstructured":"Ronco P, Debiec H. Pathophysiological lessons from rare associations of immunological disorders. Pediatr Nephrol. 2009;24(1):3\u20138.","journal-title":"Pediatr Nephrol."},{"key":"3023_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fendo.2017.00119","volume":"8","author":"D Santoro","year":"2017","unstructured":"Santoro D, Vadala C, Siligato R, Buemi M, Benvenga S. Autoimmune Thyroiditis and Glomerulopathies. Front Endocrinol (Lausanne). 2017;8:119.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"3023_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ndt\/gfs491","volume":"28","author":"X Kong","year":"2013","unstructured":"Kong X, Ma Y, Chen J, Luo Q, Yu X, Li Y, Xu J, Huang S, Wang L, Huang W, Wang M, Xu G, Zhang L, Zuo L, Wang H, Chinese e GFRIC. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant. 2013;28(3):641\u201351.","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"3023_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/jcem-42-3-504","volume":"42","author":"CW Burke","year":"1976","unstructured":"Burke CW, Shakespear RA. Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein. J Clin Endocrinol Metab. 1976;42(3):504\u201313.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"3023_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/jcem-42-3-494","volume":"42","author":"RA Shakespear","year":"1976","unstructured":"Shakespear RA, Burke CW. Triiodothyronine and thyroxine in urine. I. Measurement and application. J Clin Endocrinol Metab. 1976;42(3):494\u2013503.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"3023_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/0003-4819-90-3-335","volume":"90","author":"MA Afrasiabi","year":"1979","unstructured":"Afrasiabi MA, Vaziri ND, Gwinup G, Mays DM, Barton CH, Ness RL, Valenta LJ. Thyroid function studies in the nephrotic syndrome. Ann Intern Med. 1979;90(3):335\u20138.","journal-title":"Ann Intern Med."},{"issue":"1","key":"3023_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/00365517909104933","volume":"39","author":"E Iversen","year":"1979","unstructured":"Iversen E, Pedersen KO. Unconjugated thyroxine and triiodothyronine in urine: influence of age, sex, drugs and thyroid function. Scand J Clin Lab Invest. 1979;39(1):7\u201313.","journal-title":"Scand J Clin Lab Invest."},{"issue":"1","key":"3023_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4158\/EP.14.1.97","volume":"14","author":"V Chandurkar","year":"2008","unstructured":"Chandurkar V, Shik J, Randell E. Exacerbation of underlying hypothyroidism caused by proteinuria and induction of urinary thyroxine loss: case report and subsequent investigation. Endocr Pract. 2008;14(1):97\u2013103.","journal-title":"Endocr Pract."},{"issue":"5","key":"3023_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1507\/endocrj1954.35.733","volume":"35","author":"K Yoshida","year":"1988","unstructured":"Yoshida K, Sakurada T, Kaise K, Kaise N, Nomura T, Itagaki Y, Yamamoto M, Saito S, Yoshinaga K. Measurement of thyroid stimulating hormone (TSH) in human urine. Endocrinol Jpn. 1988;35(5):733\u20139.","journal-title":"Endocrinol Jpn."},{"issue":"1","key":"3023_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13730-013-0093-y","volume":"3","author":"K Sasaki","year":"2014","unstructured":"Sasaki K, Yasuda K, Nakanishi K, Rakugi H, Isaka Y, Yamato M. Membranous nephropathy secondary to Graves\u2019 disease with deposits of thyroid peroxidase in an adult. CEN Case Rep. 2014;3(1):90\u20133.","journal-title":"CEN Case Rep."},{"issue":"23","key":"3023_CR19","doi-asserted-by":"publisher","first-page":"e26273","DOI":"10.1097\/MD.0000000000026273","volume":"100","author":"L Zhao","year":"2021","unstructured":"Zhao L, Liu Y, Su H, Shi X. Relationship between autoimmune thyroid disease and nephropathy: A clinicopathological study. Medicine (Baltimore). 2021;100(23):e26273.","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"3023_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00467-008-0973-0","volume":"24","author":"Y Shima","year":"2009","unstructured":"Shima Y, Nakanishi K, Togawa H, Obana M, Sako M, Miyawaki M, Nozu K, Iijima K, Yoshikawa N. Membranous nephropathy associated with thyroid-peroxidase antigen. Pediatr Nephrol. 2009;24(3):605\u20138.","journal-title":"Pediatr Nephrol."},{"issue":"4","key":"3023_CR21","first-page":"223","volume":"27","author":"EI Christensen","year":"2012","unstructured":"Christensen EI, Birn H, Storm T, Weyer K, Nielsen R. Endocytic receptors in the renal proximal tubule. Physiology (Bethesda). 2012;27(4):223\u201336.","journal-title":"Physiology (Bethesda)."},{"issue":"1","key":"3023_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321.","journal-title":"N Engl J Med."},{"key":"3023_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fimmu.2020.00837","volume":"11","author":"B Huang","year":"2020","unstructured":"Huang B, Zhang Y, Wang L, Wu Q, Li T, Zhang J, Zhang Q, Sheng H, Bao J, Hu Z. Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy. Front Immunol. 2020;11:837.","journal-title":"Front Immunol."},{"issue":"1","key":"3023_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1681\/ASN.2010070766","volume":"23","author":"LH Mariani","year":"2012","unstructured":"Mariani LH, Berns JS. The renal manifestations of thyroid disease. J Am Soc Nephrol. 2012;23(1):22\u20136.","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"3023_CR25","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41598-018-19693-4","volume":"8","author":"YC Chang","year":"2018","unstructured":"Chang YC, Chang CH, Yeh YC, Chuang LM, Tu YK. Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study. Sci Rep. 2018;8(1):2031.","journal-title":"Sci Rep."},{"issue":"9","key":"3023_CR26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3109\/0886022X.2014.949559","volume":"36","author":"H Liu","year":"2014","unstructured":"Liu H, Yan W, Xu G. Thyroid hormone replacement for nephrotic syndrome patients with euthyroid sick syndrome: a meta-analysis. Ren Fail. 2014;36(9):1360\u20135.","journal-title":"Ren Fail."},{"issue":"6","key":"3023_CR27","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/thy.2012.0475","volume":"23","author":"DH Shin","year":"2013","unstructured":"Shin DH, Lee MJ, Lee HS, Oh HJ, Ko KI, Kim CH, Doh FM, Koo HM, Kim HR, Han JH, Park JT, Han SH, Yoo TH, Kang SW. Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism. Thyroid. 2013;23(6):654\u201361.","journal-title":"Thyroid."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-03023-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-03023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T13:05:49Z","timestamp":1670936749000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-03023-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3023"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-03023-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,10]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was in compliance of the Declaration of Helsinki and approved by the ethics committee of Tianjin Medical University General Hospital, approval number [IRB2022-YX-002\u201301]. All the patients agreed to participate in the study by providing the written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}